Women’s Bantamweight flagged by USADA for potential violation

December 1, 2017

UFC women’s bantamweight Amanda Lemos has been flagged for a potential UFC anti-doping violation.  The 30-year-old Brazilian has just one fight with the promotion.

Lemos lost to Leslie Smith this past July at UFC Fight Night 113.  Prior to her time with the UFC, she fought in Brazil with the Jungle Fight promotion.

Via USADA:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Amanda Lemos of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on November 8, 2017.

Payout Perspective:

The UFC will likely issue its standard comment regarding these notifications.  Lemos fought exclusively in Brazil prior to her fight in Scotland against Smith.

Another UFC Heavyweight flagged by USADA for potential violation

November 18, 2017

UFC Heavyweight James Mulheron has been notified of a potential violation of the UFC anti-doping policy and has been removed from his fight against Cyril Asker next week in Shanghai, China at UFC Fight Night 122.

Mulheron fought just once in the UFC, losing against Justin Willis at UFC Fight Night from Glasgow, Scotland.

Via UFC.com:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed James Mulheron of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on November 10, 2017. Due to the proximity of James’s upcoming scheduled bout at UFC Fight Night: Bisping vs. Gastelum in Shanghai, China on November 25, 2017, against Cyril Asker, Mulheron has been removed from the card and UFC is currently seeking a replacement.

Payout Perspective:

Yet another Heavyweight falls to USADA it appears.  It’s not clear why heavyweights may be susceptible to the anti-doping policy but it appears that this is happening more than other weight classes.  As we know, Anderson Silva was removed from this card because of a potential violation as well.

Grant Dawson flagged for potential anti-doping violation

November 11, 2017

UFC Featherweight Grant Dawson has been notified of a potential UFC anti-doping policy violation related to an October 18, 2017 test.

Dawson, 23, has yet to debut with the organization.  He was one of the fighters to win UFC contracts on Dana White’s Contender Series this summer.

Payout Perspective:

Dawson is the second fighter from the Dana White Contender Series to be flagged by USADA.  Zu Anyanwu was flagged for an out-of-competition test the same day as Dawson.  This might be one of those issues where the fighter used a supplement without knowing the contents.  Both probably started in the protocol and was not primed for the testing.  Of course, we will need to see what the substances that were flagged before making that determination.

Anderson Silva flagged for potential anti-doping violation

November 10, 2017

Anderson Silva has been flagged by USADA for a potential UFC anti-doping violation.  He has been pulled from his upcoming fight against Kelvin Gastelum in Shanghai, China on November 25th.

An out-of-competition sample collected on October 26, 2017 was flagged by USADA.  Due to the proximity of his fight which happens in 15 days, he has been removed from the bout and the UFC is looking for a replacement.

You may recall that Silva failed a drug test from his fight with Nick Diaz at UFC 183.  Silva claimed the failed test was related to a tainted sexual performance drug.  Silva served a one-year suspension and a fine of $380,000.

Payout Perspective:

This is disappointing news for Silva and the UFC.  The company had hoped it would make a splash in its debut in China.  Silva is a big name in MMA and has international appeal.  But, with his name off of the card, it will be hard in a short turnaround to find a replacement for headliner Kelvin Gastelum.  For Silva, its another mark against his great career.  We will see what Silva’s response will be on this issue.  We will also see if USADA will treat Silva’s prior offense as a prior bad act as his previous drug test occurred prior to the UFC anti-doping policy.

Anyanwu latest UFC Heavyweight to be flagged by USADA

November 4, 2017

Heavyweight Zu Anyanwu was notified of a potential UFC anti-doping violation stemming from an out-of-competition sample collected on October 18th.  As is standard, he has been provisionally suspended from the organization.

Anyanwu was one of the fighters signed to a UFC contract after appearing on Dana White’s Contender Series on Fight Pass.  In his UFC debut, he dropped a split-decision to Justin Ledet.

The UFC released its standard statement when USADA notifies it about a flagged test:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Azunna Anyanwu of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on October 18, 2017.

Payout Perspective:

Anyanwu is the latest heavyweight to be flagged for a potential violation.  Ion Cutelaba was taken off of UFC 217 due to a violation from a test at about the same timeframe as Anyanwu.  Carlos Felipe was flagged this past September.  In addition, Junior, Dos Santos, Ben Rothwell and Josh Barnett have been flagged by USADA.  It would be interesting to look at the circumstances surrounding each of their drug test failures.

Heavyweight removed from UFC 217 for potential anti-doping violation

November 3, 2017

UFC Heavyweight Ion Cutelaba has been taken off of tomorrow’s UFC 217 event due to a potential anti-doping policy violation per the company.

USADA launched an investigation into Cutelaba because of a voluntary disclosure made during out-of-competition sample collections on October 18th and 19th.  He has been put on provisional suspension and his bout with Gadzhimurad Antigulov is off.

The UFC released its standard statement which reads:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Ion Cutelaba of a potential Anti-Doping Policy violation stemming from its investigation into voluntary disclosures by Cutelaba during an out-of-competition sample collections on October 18 and October 19, 2017. USADA has provisionally suspended Cutelaba and his fight against Michal Oleksiejczuk has been cancelled from the November 4, 2017, UFC 217 fight card.

Payout Perspective:

With every fighter making weight on Friday, everyone had thought that all fights would go on without a problem.  But, Cutelaba’s removal takes away one fight from UFC 217.  It also means that we will not see the Hulk at the ceremonial weigh-ins.  For the 23 year old, the issue appears to be something that was disclosed on his form and one would hope that it might be clarified and/or mitigated.

Good files lawsuit against supplement maker, Vitamin Shoppe

October 24, 2017

Lyman Good has filed a lawsuit against Gaspari Nutrition, Richard Gaspari, Hi-Tech Pharmaceuticals, Jared Wheat and Vitamin Shoppe as a result of a failed UFC drug test.  Good alleges that a vitamin supplement he took was not properly labelled and contained a banned substance.

The target supplement is Anavite according to the lawsuit which was filed in New York by his attorney, David Fish.

Good was suspended for violating the UFC Anti-Doping Policy after he failed a random test.  As part of the process, he learned that the drug that may have caused the failed test was Anavite.

Good is requesting restitution, damages, injunctive and other equitable relief.  Good believes that Gaspari Nutrition misbranded the products as “dietary supplements” to defraud consumers into the believing it had superior “dietary supplements.”

Vitamin Shoppe was sued for (among other things) breach of warranty for selling the products “despite assurances of product quality and control.”  The store claims to have safety measures to ensure that the products its sells are of quality.  Good claims that it has failed to provide such safeguards based on the product he purchased from the store.

Upon learning of the flagged USADA test, Good had provided USADA with unopened packages of Anavite to examine at a lab regarding the contents.  The results confirmed Andro in the product.  Andro is a banned substance per the UFC Anti-Doping Policy and considered a steroid.  Thus, Good has sued the supplement maker, its owners and the store that sold the product.  The lawsuit indicates the harmful effects of steroids and the fact that Andro is such a substance

The lawsuit embeds a picture of the product and its contents which is listed as a “dietary supplement”.  Andro is considered “adulterated” and misbranded according to Good.

There are several causes of action in this lawsuit including products liability, fraud and intentional infliction of emotional distress.

Good was taken off the New York City card last November as a result of the failed test.

Payout Perspective:

This is a first of its kind lawsuit under the UFC Anti-Doping Policy and perhaps MMA.  Good can show he was damaged due to the fact that he relied on the representation of the label that Anavite did not contain Andro as it was not on its label as a content and was listed as a “Dietary Supplement.”  He is making a claim against Vitamin Shoppe since it claims to have superior knowledge of these products and should have investigated this product.  The defendants will likely claim a tainted product and that overall, its products do not contain the banned substance.  Moreover, it will claim that there are no damages incurred by Good despite serving a six month sentence.

In products liability cases (lawsuits where the claim is that a product is defective), there is a higher standard on the manufacturer or seller to ensure that the user is not harmed.  In this instance, one could argue Good was not harmed in the sense of physical injury.  He was harmed since he had to ensure he did not ingest a banned substance per the UFC Anti-Doping Policy.  This will make a very interesting case as it continues.  MMA Payout will continue to follow.

UFC Heavyweight accepts USADA’s two-year sanction

October 20, 2017

Carlos Felipe has accepted a two-year sanction for a violation of the UFC Anti-Doping Policy.  The 22-year-old Brazilian Heavyweight’s UFC career is suspended before it ever began.

Felip tested positive for stanozolol metabolites, 16β-hydroxy-stanozolol and 3’hydroxy-stanozolol.  Per the USADA release, “Stanozolol is a non-Specified Susbstance in the category of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World-Anti-Doping Agency Prohibited List.  Stanozolol is sometimes used to lose fat while retaining lean body mass.

Felipe was set for his debut fight in the UFC card in Sao Paulo, Brazil on October 28th but an out of competition test on July 29th was flagged by USADA.  Prior to the UFC, he was 8-0 in his pro career.

Payout Perspective:

It’s a stiff penalty but at 22, Felipe can still return to the UFC (if they will want him) and still have a long MMA career.  Accepting the penalty likely meant that he did not have a good reason for the flagged test and it was better than attempting a lengthy legal battle.

 

 

Little Nog notified of potential USADA violation

October 19, 2017

Antonio Rogerio Nogueira has been flagged for a potential violation of the UFC Anti-Doping Policy.  The light heavyweight’s upcoming fight against Jared Cannonier has been scratched with The Killa Gorilla awaiting for a replacement.

The UFC released its standard statement regarding these matters.  A portion of which reads:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Antonio Rogerio Nogueira of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on September 27, 2017. Due to the proximity of Nogueira’s upcoming scheduled bout at UFC FIGHT NIGHT: LAWLER vs. DOS ANJOS in Winnipeg, Canada on December 16, 2017 against Jared Cannonier, Nogueira has been removed from the card and the UFC is currently seeking a replacement.

Payout Perspective:

If Nogueira cannot absolve himself of this wrongdoing, it could spell the end for the 41-year-old’s career in the UFC.  This would be Nogueira’s first violation which would be a 2-year sanction unless he is able to mitigate the case with USADA.

Jesse Taylor accepts 1-year USADA suspension

October 14, 2017

USADA announced that UFC welterweight Jesse Taylor has accepted a 1-year suspension for his use of Clomiphene.  The TUF Champion will not be able to return to the Octagon until September 2018.

Via USADA news release:

Taylor, 34, tested positive for clomiphene following an out-of-competition urine test conducted on August 22, 2017. Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.

Clomiphene is not approved by the U.S. Food & Drug Administration (FDA) for use in the male population, as its use has not been thoroughly studied for safety and efficacy. Clomiphene also indirectly promotes the secretion of testosterone. Increasing testosterone, especially when combined with strength training, has been demonstrated to increase fat-free mass, muscle size, and strength in males, potentially leading to performance enhancement in sport.

Taylor’s one-year period of ineligibility, the highest sanction for a first offense involving a Specified Substance, began on September 13, 2017, the date his provisional suspension was imposed. As a result of his positive test, Taylor was removed from the Card for the UFC Fight Night event in Sydney, Australia, scheduled for November 18, 2017.

Payout Perspective:

Perhaps the only recourse for Taylor without expending a lot of legal costs.  Also, if he did not have a true excuse for his testing, it would only prolong the administrative battle.  It’s too bad for Taylor who just made it back into the organization.  The suspension also brings to light the issue of Clomiphene, a fertility drug for women, and the use of it by male competitors.

Next Page »